August 22, 2008 — Concomitant zoledronic acid (Zometa, Novartis) that is given during adjuvant endocrine therapy can prevent bone loss in premenopausal breast cancer patients. It also improves ...
A recent study by the University of Eastern Finland is the first to report that the fatty acid composition of blood and the enzyme activity associated with it predict the development of bone mineral ...
May 4, 2010 (Barcelona, Spain) — Monthly infusions of the bisphosphonate zoledronic acid significantly reduce the risk for bone fractures in men with prostate cancer and malignant bone metastases, ...
New research reveals that oleic acid, abundant in olive oil, protects aging mice from gum infection-induced bone loss and gut microbiome disruption, highlighting how what we eat may help prevent ...
A successful beauty routine is more than skin deep.